The adipose tissue field is translating from plastic surgery to possible regenerative purposes.!--h2>
Enal Razvi, Ph.D.
This report represents our continuing coverage of the potential utilization of adipose tissue and its associated components (such as the stem cells contained therein) as a means for mediating regenerative medicine.
Highlights of this report:
The current use of fat for cosmetic and reconstructive purposes provides the raison d’être for its deployment for regenerative medicine/cellular therapy.
More work remains to identify the component[s] within adipose tissue responsible for its regenerative properties—Is it the cells? The scaffold? The cytokine milieu? Much is unclear at present.
These results lend credibility to the notion that early clinical results could provide a good rationale for deeper investigations for mechanism of action; the case here demonstrates that clinicians utilizing adipose-derived cells as a means for addressing musculoskeletal and other conditions provide a good foundation for exploring the regenerative potential of this tissue.
Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and subsequent to receiving his Ph.D. went on to the Rockefeller University in New York to serve as Aaron Diamond Post-doctoral fellow under Professor Ralph Steinman [Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Zanvil Cohn]. Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at email@example.com.